Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

119
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
119

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

European journal of cancer (Oxford, England : 1990)·2026
Same author

A Spotlight on Yolk-sac Tumors: Molecular Pathology, Current Diagnostics, and Novel Therapeutics.

Andrology·2026
Same author

Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.

Antibiotics (Basel, Switzerland)·2026
Same author

Multimodal AI-driven analysis in breast and lung cancer: insights from the OPTIMA prototyping workshop.

BMC proceedings·2026
Same author

Pharmacological inhibition of host cell neddylation reduces intoxication of cells by diphtheria toxin and clostridial enterotoxins TcdB and C2.

Microbiology spectrum·2026
Same author

Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis.

European journal of cancer (Oxford, England : 1990)·2025
Same journal

Efficacy of Honey Combined with Cryotherapy in the Prevention and Management of Radiation-Induced Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Head and Neck Cancer.

Oncology research and treatment·2026
Same journal

Three therapeutic modalities for advanced ovarian cancer: real world data from a certified oncological center.

Oncology research and treatment·2026
Same journal

Real world experiences in the treatment of immune thrombocytopenia over a two-year period.

Oncology research and treatment·2026
Same journal

Safety and preliminary activity of neoadjuvant trastuzumab deruxtecan (T-DXd) plus 5-fluorouracil and folinic acid for HER2-positive, resectable esophagogastric adenocarcinoma: Results from the safety run-in cohort of the phase Ib/II UCCL-AIO-STO0124-IKF072 NeoART trial.

Oncology research and treatment·2026
Same journal

Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-invasive Bladder Cancer.

Oncology research and treatment·2026
Same journal

The Role of Regulatory Policies in Shaping Outpatient Cancer Treatment in Germany: A Comparative Perspective.

Oncology research and treatment·2026
See all related articles

Related Experiment Video

Updated: Jul 30, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

867

Early Detection of Pancreatic Cancer.

Jérôme Schwingel1, Miriam Decker1, Lisa Schneider1

  • 1Internal Medicine and Gastroenterology, Caritasklinikum St. Theresia, Saarbruecken, Germany.

Oncology Research and Treatment
|May 11, 2023
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer screening is not recommended for the general population. Identifying individuals at high risk, including those with new-onset diabetes, is key for early detection and improved survival.

Keywords:
New-onset diabetesPancreatic cancerScreeningSymptoms

More Related Videos

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
06:57

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

Published on: April 7, 2018

10.9K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.4K

Related Experiment Videos

Last Updated: Jul 30, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

867
Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
06:57

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

Published on: April 7, 2018

10.9K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.4K

Area of Science:

  • Oncology
  • Gastroenterology
  • Medical Diagnostics

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a prevalent and aggressive cancer.
  • Current pancreatic cancer screening methods are not well-established for early detection.
  • Early diagnosis may improve patient survival, but evidence is limited.

Purpose of the Study:

  • To summarize current recommendations for pancreatic cancer screening.
  • To identify patient groups who could benefit from screening.
  • To review novel screening approaches.

Main Methods:

  • Literature search for current screening recommendations.
  • Analysis of patient groups with increased pancreatic cancer risk.
  • Evaluation of emerging diagnostic technologies.

Main Results:

  • Screening is not recommended for the general population due to low prevalence and lack of survival benefit evidence.
  • Novel approaches like liquid biopsies show potential but are not yet effective for unselected individuals.
  • Screening is more effective in individuals with a higher pretest probability of PDAC.

Conclusions:

  • High-risk individuals, including those with specific genetic alterations or new-onset diabetes (especially with weight loss in the elderly), should be prioritized for screening.
  • Targeted screening in well-defined populations can be performed with common diagnostic methods.
  • Identifying high-risk individuals is the most effective strategy for improving early pancreatic cancer diagnosis.